Connection
Mark Abzug to Evidence-Based Medicine
This is a "connection" page, showing publications Mark Abzug has written about Evidence-Based Medicine.
|
|
Connection Strength |
|
|
|
|
|
0.073 |
|
|
|
-
Chiotos K, Hayes M, Kimberlin DW, Jones SB, James SH, Pinninti SG, Yarbrough A, Abzug MJ, MacBrayne CE, Soma VL, Dulek DE, Vora SB, Waghmare A, Wolf J, Olivero R, Grapentine S, Wattier RL, Bio L, Cross SJ, Dillman NO, Downes KJ, Oliveira CR, Timberlake K, Young J, Orscheln RC, Tamma PD, Schwenk HT, Zachariah P, Aldrich ML, Goldman DL, Groves HE, Rajapakse NS, Lamb GS, Tribble AC, Hersh AL, Thorell EA, Denison MR, Ratner AJ, Newland JG, Nakamura MM. Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2. J Pediatric Infect Dis Soc. 2021 Feb 13; 10(1):34-48.
Score: 0.035
-
Abzug MJ. Meeting the challenge of antibiotic resistance: an evidence-based approach to treatment. Pediatr Ann. 1999 Jul; 28(7):460-7.
Score: 0.031
-
Chan KH, Winslow CP, Levin MJ, Abzug MJ, Shira JE, Liu AH, Simoes EA, Strain JD, Stool SE. Clinical practice guidelines for the management of chronic sinusitis in children. Otolaryngol Head Neck Surg. 1999 Mar; 120(3):328-34.
Score: 0.008
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|